Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation

Published:2024 Issue: Volume:46 Page:101461
ISSN:2352-9148
Container-title:Informatics in Medicine Unlocked
language:en
Short-container-title:Informatics in Medicine Unlocked

Author:

Egejuru Winner Amaka,Aderemi Olajide Enoch,Egbemhenghe Abel Ujaigbe,Ali Muhammad Qasim,Opasina Dolapo Emmanuel,Agadagba Cyril Obaro,Oladokun Emmanuel Parkay,Abdulrazaq Ibrahim Tope,Ayinla Maryam Folake,Bamidele Abiodun,Alayemi Olamide Oluwagbeminiyi,Adebowale Latifat Akorede,Adebayo Folakemi Monsurat,Omotara Bamidele Samson

Publisher

Elsevier BV

Reference27 articles.

1. Immune checkpoint receptors signaling in T cells;Baldanzi;Int J Mol Sci,2022

2. Immune checkpoint inhibitors in cancer therapy;Shiravand;Curr Oncol,2022

3. The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: lessons learned and the road ahead;Hosseinkhani;Front Immunol,2021

4. VISTA: a mediator of quiescence and a promising target in cancer immunotherapy;Yuan;Trends Immunol,2021

5. VISTA: a promising target for cancer immunotherapy?;Tagliamento;ImmunoTargets Ther,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP